Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Sep 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1984901000001119 | HYNIC-[D-Phe1, Tyr3-octreotide] TFA salt | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1984921000001114 | HYNIC-[D-Phe1, Tyr3-octreotide] TFA salt (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| HYNIC-[D-Phe1, Tyr3-octreotide] TFA salt | Is a | Somatostatin analog | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Generic Tektrotyd 16microgram kit for radiopharmaceutical preparation | Has specific active ingredient | True | HYNIC-[D-Phe1, Tyr3-octreotide] TFA salt | Inferred relationship | Existential restriction modifier | |
| Generic Tektrotyd 16microgram kit for radiopharmaceutical preparation 1 kit | Has specific active ingredient | True | HYNIC-[D-Phe1, Tyr3-octreotide] TFA salt | Inferred relationship | Existential restriction modifier | |
| Tektrotyd 16microgram kit for radiopharmaceutical preparation (Xiel Ltd) 1 kit | Has specific active ingredient | True | HYNIC-[D-Phe1, Tyr3-octreotide] TFA salt | Inferred relationship | Existential restriction modifier | |
| Tektrotyd 16microgram kit for radiopharmaceutical preparation (Xiel Ltd) | Has specific active ingredient | True | HYNIC-[D-Phe1, Tyr3-octreotide] TFA salt | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR